Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec:196:272-275.
doi: 10.1016/j.thromres.2020.09.015. Epub 2020 Sep 13.

Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation

Domenico Paparella  1 , Mario Colucci  2 , Enrico Squiccimarro  3 , Pasquale Raimondo  2 , Federica De Palma  4 , Prudenza Ranieri  5 , Maria Addolorata Mariggiò  6 , Salvatore Grasso  4
Affiliations
Comment

Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation

Domenico Paparella et al. Thromb Res. 2020 Dec.
No abstract available

Keywords: ARDS; COVID-19; Coagulopathy; Coronavirus; Disseminated intravascular coagulation; Inflammation.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Time-course of inflammatory markers and SOFA score in patients with COVID-19 admitted to ICU. Data represent mean ± SEM. The dotted lines represent the upper limit or the range of the reference values for each assay.
Fig. 2
Fig. 2
Time-course of coagulation markers in patients with COVID-19 admitted to ICU. Data represent mean ± SEM or mean and extreme values (DIC score). The dotted lines represent the upper limit or the range of the reference values for each assay.
See this image and copyright information in PMC

Comment on

References

    1. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Tang N., Bai H., Chen X. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020 doi: 10.1111/jth.14817. published online March 27. - DOI - PMC - PubMed
    1. Panigada M., Bottino N., Tagliabue P. Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 2020 doi: 10.1111/jth.14850. published online April 17, 2020. - DOI - PMC - PubMed
    1. Spiezia L., Boscolo A., Poletto F. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb. Haemost. 2020 doi: 10.1055/s-0040-1710018. Published online April, 21. - DOI - PMC - PubMed
    1. Levi M., Toh C.H., Thachil J. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br. J. Haematol. 2009;145:24–33. doi: 10.1111/j.1365-2141.2009.07600.x. - DOI - PubMed